Etanercept is a fusion protein of the extracellular domains of p75 and p55 TNF-α receptor and the Fc fragment of human immunoglobulin G. International guidelines have concluded that there is no evidence to support the use of etanercept in the management of uveitis [2,8,48]. Here, TNFRSF1A is linked to uveitis.